Insider filing · KRYS
John Charles Thomas
EVP, General Counsel
profile →
Krystal Biotech, Inc.
KRYS · Healthcare · 25 filings in 24 months
ticker →
John Charles Thomas sold $347K of Krystal Biotech (KRYS)
Executed Jun 25, disclosed Jun 26, 1 day later.
Value, as filed
$347K
1,000 sh × $347.27
Executed
Jun 25
the trade date, as filed
Disclosed
Jun 26
1 day after the trade
Return, 21 sessionsiFrom the disclosed entry session; derived
–
purchases only
Returns are measured on stock purchases only.
The filer
JTJohn Charles Thomas (EVP, General Counsel) filed 2 Form 4 reports in the trailing twelve months (0 purchases, 2 sales), most often in Krystal Biotech, Inc. (KRYS). The largest single filing was $347K of KRYS (1,000 sh × $347.27, as filed), executed Jun 25.
The name
KRYSHealthcare · Krystal Biotech, Inc., a commercial-stage biotechnology company, discovers, develops, manufactures, and commercializes genetic medicines to…
More Healthcare filings→ Insider filings, newest first→ View the original filing at www.sec.gov→Other filings by John Charles Thomas in KRYS
KRYSSALE
Krystal Biotech, Inc.
$194K642 sh × $302.03
Exec May 26
Filed May 27 · 5:30 PM ET